(GLY14)-HUMANIN (HUMAN)
(GLY14)-HUMANIN (HUMAN) Basic information
- Product Name:
- (GLY14)-HUMANIN (HUMAN)
- Synonyms:
-
- MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-GLY-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA
- MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-GLY-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA TRIFLUOROACETATE
- MAPRGFSCLLLLTGEIDLPVKRRA
- H-MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-GLY-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA-OH
- MAPGSGCLLLLTGEIDLPVKRRA
- [GLY14]-HN
- [GLY14]-HUMANIN
- [GLY14] HUMANIN G (HNG), HUMAN
- CAS:
- 330936-70-4
- MF:
- C118H202N34O31S2
- MW:
- 2657.21
- Product Categories:
-
- peptide
- Alzheimers and Neurodegenerative Disease Research
- Neurobiology
- Neurodegenerative Disease Peptides
- Other Alzheimer Peptides
- OtherNeuropeptides
- Mol File:
- 330936-70-4.mol
(GLY14)-HUMANIN (HUMAN) Chemical Properties
- storage temp.
- −70°C
- form
- solid
- color
- White to off-white
- biological source
- human
- Water Solubility
- water: 1.00-1.04mg/mL, clear, colorless
- InChIKey
- WUYRHUFIUFJVQU-LIRFXKSTNA-N
MSDS
- Language:English Provider:SigmaAldrich
(GLY14)-HUMANIN (HUMAN) Usage And Synthesis
Uses
[Gly14]-Humanin G human has been used:
- along with bortezomib in pharmacological inhibition studies to tre at mice to limit the toxic effects of bortezomib
- to study its effect on high glucose (HG)-induced apoptosis of endothelial cells (ECs)
- to study its neuroprotective effects in an in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) model using SH-SY5Y neuroblastoma cells
Biological Activity
Endogenous rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimerμs disease genes and Aβ', '[Gly14]-humanin (HNG) stimulates cell growth, proliferation, and cell cycle progression. It enhances proteins such as kinases, transporters, transmembrane receptors, and transcription and translational regulators. HNG exhibits intense in vitro neuroprotective effects compared to natural HN. Studies show th at it is an effective cytoprotectant both in vitro and in vivo. HNG is found to prevent high glucose (HG)-induced apoptosis of endothelial cells (ECs). It is proven to inhibit AngII-induced phenotypic switch in vascular smooth muscle cells (VSMCs).
in vivo
(Gly14)-Humanin (human) (0.1 μg/5 μL; i.c.v.; once) decreases cells with plasmalemma permeability in the injured cortex and hippocampus, reduces brain lesion volume, improves motor performance and ameliorates performance in the Morris water maze test[2].
| Animal Model: | Adult male CD-1 mice (25-30 g; 10-12-week-old) bearing traumatic brain injury (TBI)[2] |
| Dosage: | 0.1 μg/5 μL |
| Administration: | Intracerebroventricularly (i.c.v.); once |
| Result: | Decreased cells with plasmalemma permeability in the injured cortex and hippocampus, reduced brain lesion volume, improved motor performance. |
(GLY14)-HUMANIN (HUMAN)Supplier
- Tel
- 512-58900862 400-0707518
- sales@alabiochem.com
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 0551-65326643 18156095617
- info@cellmano.com